2013
DOI: 10.7717/peerj.152
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia-inducible C-to-U coding RNA editing downregulatesSDHBin monocytes

Abstract: Background. RNA editing is a post-transcriptional regulatory mechanism that can alter the coding sequences of certain genes in response to physiological demands. We previously identified C-to-U RNA editing (C136U, R46X) which inactivates a small fraction of succinate dehydrogenase (SDH; mitochondrial complex II) subunit B gene (SDHB) mRNAs in normal steady-state peripheral blood mononuclear cells (PBMCs). SDH is a heterotetrameric tumor suppressor complex which when mutated causes paraganglioma tumors that are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
25
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1
1

Relationship

4
6

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 40 publications
(48 reference statements)
0
25
0
Order By: Relevance
“…The most frequently mutated SDH genes are SDHB and SDHD , with only a few mutations detected in SDHC , whereas SDHA or SDHAF genes are rarely mutated (Kim et al , ; Tretter, Patocs, & Chinopoulos, ). Besides the mutational status of SDH subunits, it is emerging that SDH expression/activity might also be regulated: ( i ) at a transcriptional or post‐transcriptional level, by epigenetic suppression of SDH subunit expression (Baysal, ; Richter et al , ), by RNA non‐sense mutation due to C‐to‐U RNA editing that has been demonstrated to reduce the SDHB functional transcript dynamically in monocytes (Baysal et al , ), and by the expression of microRNAs (miRNAs) targeting SDH messenger RNAs (mRNAs) (Eichner et al , ; Tsang et al , ; Lee et al , ); and ( ii ) at a post‐translational level, by the inhibition of SDH activity, for example through the binding of the chaperone tumour necrosis factor receptor‐associated protein 1 (TRAP‐1) (Sciacovelli et al , ) or through the competitive inhibition of the metabolite itaconate in activated macrophages (Lampropoulou et al , ), or by the regulation of SDH phosphorylation through protein tyrosine phosphatase mitochondrial 1 (PTPMT1) (Nath et al , ), feline Gardner‐Rasheed sarcoma viral oncogene homolog (Fgr) tyrosine kinase (Salvi et al , ), or avian sarcoma (Schmidt‐Ruppin A‐2) viral oncogene homolog (c‐Src) tyrosine kinase (Ogura et al , ).…”
Section: Oncometabolites and Their Related Metabolic Enzymesmentioning
confidence: 99%
“…The most frequently mutated SDH genes are SDHB and SDHD , with only a few mutations detected in SDHC , whereas SDHA or SDHAF genes are rarely mutated (Kim et al , ; Tretter, Patocs, & Chinopoulos, ). Besides the mutational status of SDH subunits, it is emerging that SDH expression/activity might also be regulated: ( i ) at a transcriptional or post‐transcriptional level, by epigenetic suppression of SDH subunit expression (Baysal, ; Richter et al , ), by RNA non‐sense mutation due to C‐to‐U RNA editing that has been demonstrated to reduce the SDHB functional transcript dynamically in monocytes (Baysal et al , ), and by the expression of microRNAs (miRNAs) targeting SDH messenger RNAs (mRNAs) (Eichner et al , ; Tsang et al , ; Lee et al , ); and ( ii ) at a post‐translational level, by the inhibition of SDH activity, for example through the binding of the chaperone tumour necrosis factor receptor‐associated protein 1 (TRAP‐1) (Sciacovelli et al , ) or through the competitive inhibition of the metabolite itaconate in activated macrophages (Lampropoulou et al , ), or by the regulation of SDH phosphorylation through protein tyrosine phosphatase mitochondrial 1 (PTPMT1) (Nath et al , ), feline Gardner‐Rasheed sarcoma viral oncogene homolog (Fgr) tyrosine kinase (Salvi et al , ), or avian sarcoma (Schmidt‐Ruppin A‐2) viral oncogene homolog (c‐Src) tyrosine kinase (Ogura et al , ).…”
Section: Oncometabolites and Their Related Metabolic Enzymesmentioning
confidence: 99%
“…The supplement of succinate is similar to succinate metabolism in the ischemia-reperfusion model, and elevated succinate may upregulate SDH transcription by substrateenzyme interaction [44], leading to enhanced SDH transcription as Figure 4(d). As shown in Figure 4(a), intracellular succinate levels peaked at 6 h; such high concentration of intracellular succinate may significantly affect its protein expression and activity by several possible mechanisms: succinate may stabilize HIF-1α to mimic hypoxic state, which triggers hypoxia-inducible C-to-U coding RNA editing [45], and miRNA-mediated epigenetic regulation may also contribute to transcription modification [46]; in addition, extensive ROS generation by reverse electron transport (RET) at mitochondrial complex I during oxidation of succinate may critically affect the availability of reduced NAD + and altered activity of SIRT3, a NAD-dependent deacetylase that affects SDH enzymatic activity [47]; moreover, succinate accumulation in the mitochondrial may increase levels of itaconate, which further inhibit SDH activity [46].…”
mentioning
confidence: 99%
“…MEPs were prepared from PBMCs using the cold aggregation method with slight modification as described. 28 Briefly, PBMCs were subjected to gentle rocking at 4 C for an hour and aggregated cells that sedimented through fetal bovine serum (FBS; VWR Ò , Radnor, PA) were collected after 8-16 hours for mild monocyte enrichment (»20%¡40% monocytes).…”
Section: Isolation and Culture Of Cellsmentioning
confidence: 99%